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Abstract
The influenza D virus (IDV) was discovered less than ten years ago. Increased inter-
est in this virus is due to its nature (RNA virus with high mutation rate), its worldwide 
circulation in livestock species, its probable role in bovine respiratory disease and 
its zoonotic potential. Until currently, the establishment of positivity cut-off of the 
hemagglutination inhibition (HI) assay was not formalized in field conditions for the 
detection of antibodies directed against IDV in cattle (i.e. the proposed reservoir). In 
this study, the positivity cut-off of the HI assays was formally established (titre = 10) 
using a receiver operating characteristic (ROC) curve. This information was used to 
estimate the sensitivity (68.04 to 73.20%) and the specificity (94.17 to 96.12%) of 
two different HI assays (HI1 and HI2, with two different IDV antigens) relatively to 
virus micro-neutralization test (VNT) as reference test. Based on the above charac-
teristics, the true prevalence of IDV was then estimated in Morocco using a stochas-
tic approach. Irrespective of the HI assays used, the estimation of the true prevalence 
was statistically equivalent (between 48.44% and 48.73%). In addition, the Spearman 
rank correlation between HI titres and VNT titres was statistically good (0.76 and 
0.81 for HA1 and HA2, respectively). The positive (0.82 and 0.79 for HA1 and HA2, 
respectively) and the negative (0.86 and 0.85 for HA1 and HA2, respectively) agree-
ment indices between results of HI assays and VNT were good and similar. This study 
allowed for a formal establishment of a positivity cut-off in HI assays for the detec-
tion of antibodies directed against IDV. This information is of prime importance to 
estimate the diagnostic sensitivity and specificity of the test relatively to the VNT (i.e. 
the reference test). Using these characteristics, the true prevalence of IDV should be 
determined in a country.
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1  | INTRODUC TION
In 2011, a new influenza D virus (IDV) was isolated from pigs with 
influenza-like clinical signs in Oklahoma, USA (Hause et al., 2014; 
Hause et al., 2013). Since then, IDV has been detected in a large 
host range and worldwide, i.e. IDV affected cattle, small rumi-
nants, swine, camelids and equines in America, Europe, Asia and 
Africa (Dane et al., 2019; Ferguson et al., 2015; Flynn et al., 2018; 
Murakami et al., 2019; O'Donovan, Donohoe, Ducatez, Meyer, & 
Ryan, 2019; Oliva, Eichenbaum, et al., 2019; Salem et al., 2017; 
Silveira et al., 2019; Snoeck et al., 2018; Trombetta et al., 2019).
The zoonotic potential of IDV is still not completely eluci-
dated, but serological and virological studies suggested that the 
virus might infect human (e.g. Borkenhagen et al., 2018; Hause 
et al., 2013), especially exposed to cattle (White, Ma, McDaniel, 
Gray, & Lednicky, 2016). Despite the absence of clinical signs, the 
virus replicated in the upper respiratory tract of the ferrets (a good 
model for studying human influenza virus) and a direct contact 
transmission between ferrets was observed (Hause et al., 2013). In 
addition, a recent study confirmed that IDV efficiently replicates 
in an in vitro surrogate model of the respiratory epithelium at tem-
peratures that correspond to the human upper and lower respira-
tory tract (Holwerda et al., 2019). All these results suggested that 
human could be susceptible to IDV, but studies are still needed to 
confirm this hypothesis (Oliva, Mettier, et al., 2019).
Among livestock species, cattle are the most affected host, in 
which the virus causes moderate respiratory clinical signs alone (e.g. 
Salem et al., 2019; Ferguson et al., 2016), but may also play a role in 
the bovine respiratory complex (e.g. Salem et al., 2019; Zhang, Hill, 
et al., 2019; Zhang, Outlaw, et al., 2019). Consequently, cattle have 
been proposed as the natural reservoir of IDV (Moreno et al., 2019).
To prevent and control the worldwide spread and inter-species 
transmission of IDV, options can be proposed such as the devel-
opment of an efficacious vaccine or the development of antiviral 
strategies (Asha & Kumar, 2019). Unfortunately, due to the inher-
ent instability and high mutation rate of influenza genomes, most 
current antivirals are no longer effective at inhibiting influenza virus 
replication (Kesinger et al., 2018) and the use of antivirus in animals 
is thus not advised. However, there are some encouraging develop-
ments in the field of vaccination. An inactivated influenza D virus 
vaccine partially protected cattle from respiratory disease caused 
by homologous challenge (Hause et al., 2017). In another study, a 
DNA vaccine encoding the consensus hemagglutinin-esterase fu-
sion (HEF) protein of two lineages of IDV (D/OK and D/660) was 
designed and its efficacy was tested in a guinea pig model. This con-
sensus DNA vaccine elicited high-titre neutralizing antibodies and 
achieved sterilizing protection against two lineage-representative 
IDV intranasal infections (Wan et al., 2018; Yu et al., 2017).
The direct diagnosis of the IDV is based mainly on isolation of 
the virus (e.g. Ferguson et al., 2015) and real-time polymerase chain 
reaction (PCR) methods (e.g. Faccini et al., 2017). These methods 
contributed to the understanding of the molecular epidemiology of 
IDV. The indirect diagnosis of IDV aims at measuring serum antibody 
to IDV, with mainly virus neutralization (VNT) and hemagglutina-
tion inhibition (HI) assays (Moreno et al., 2019). Although there are 
valuable serologic methods, VNT requires live IDV, well-trained 
staff and time (Gauger & Vincent, 2020). In addition, a monoclo-
nal antibody-based competitive ELISA test was developed recently 
and validated for the detection of antibodies against IDV (Moreno 
et al., 2019). However, in the absence of a commercial ELISA test, 
the hemagglutination inhibition assay is still often used to estimate 
the apparent prevalence of the disease. However, the positivity 
cut-off value of this test had not been formally established.
Further studies are needed to better understand the role of IDV 
in respiratory infections, especially in cattle, and to evaluate the cost–
benefit ratio of mitigation measures (control and prevention) (Oliva, 
Salem, Meyer, & Ducatez, 2018). To estimate the cost of IDV, the true 
prevalence of the disease should be assessed. This true prevalence (at 
population level) can be estimated based on the apparent prevalence 
using available serological test for which the characteristics must be 
properly known (sensitivity and specificity) (Rogan & Gladen, 1978).
The first aim of this study was to properly assess the positivity 
cut-off of HI assays with two distinct antigens relatively to VNT as the 
gold standard test and using a receiver operating characteristic (ROC) 
curve, and subsequently, the characteristics of sensitivity and speci-
ficity of these assays in the cattle population (i.e. the proposed natural 
reservoir) and a dataset from Salem et al., 2017. Secondly, the true 
prevalence was estimated in Morocco based on both the estimation of 
the characteristics of HI assays and the apparent prevalence.
2  | MATERIAL S AND METHODS
2.1 | Data selection
Morocco has 3.2 million head of cattle. A total of 200 cattle sera 
were sampled between 2012 and 2015, in different geographical 
areas of Morocco (Table 1, Salem et al., 2017). This sample size was 
determined using the population size (see above), an expected IDV 
animal prevalence of 25%, with an accepted error of 6% and a confi-
dence level of 95%, that is, 201 samples (rounded to 200).
2.2 | Laboratory analyses
Hemagglutination inhibition assay and virus micro-neutralization test 
(VNT) were performed as described previously (Salem et al., 2017).
2.2.1 | Hemagglutination inhibition (HI) assay
The sera were all treated with receptor destroying enzyme (RDE) 
(Seika) and heme adsorbed on packed horse red blood cells. Four 
hemagglutination units of D/bovine/Nebraska/9–5/2012 kindly 
provided by Dr. Ben Hause and subsequently named HI1 or D/
bovine/France/5920/2014 and subsequently named HI2 and 1% 
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horse red blood cell were used for HI assays. As IDV harbours 
hemagglutinin-esterase fusion proteins on its surface, which he-
magglutinate in presence of red blood cells of chicken, turkey or 
horse origin, the HI test can be used for IDV antibodies detection.
2.2.2 | Virus micro-neutralization test
The VNT was carried out on swine testis cells (ATCC), using 100 tissue 
culture infectious doses 50 per well (D/bovine/France/5920/2014) 
and 5 days’ incubation at 37°C and 5% CO2 without TPCK trypsin 
and an hemagglutination assay as a readout (with 1% red blood cells). 
We use D/bovine/France/5920/2014 that grows to higher titres on 
cells than D/bovine/Nebraska/9–5/2012 in our laboratory conditions.
VNT titres tested were <10, 20, 30, 40, 60, 80, 160, 320, 640 and 
1,280. VNT titres were considered positive when ≥10. For future sta-
tistical analyses, a titre <10 was assimilated as 5 (middle bound value).
Positive IDV reference serum was produced in house by in-
oculating rabbits subcutaneously with purified D/bovine/
Nebraska/9–2/2012. We also used IDV positive French cattle serum 
(from an experimental infection).
As no negative IDV reference serum was available (specific 
pathogen free calves do not exist), we used some sera from few co-
horts as negative controls, both from the field and uninfected con-
trols from experimental infections (Oliva, Eichenbaum, et al., 2019; 
Salem et al., 2017, 2019).
2.3 | Statistical analyses
2.3.1 | Receiver operating characteristic 
(ROC) curve
The receiver operating characteristic (ROC) curve was used to deter-
mine the best cut-off of HI1 and HI2 related to the VNT as reference. 
The ROC is a probability curve. The ROC curve was plotted with true 
positive results (Y-axis) against the false positive results (X-axis). The 
area under the ROC curve (AUC) is the performance measurement 
for the classification test at various threshold settings. The higher 
the AUC, the better the test is able to distinguish between infected 
and healthy cattle (i.e. measure of the separation of the two sub-
populations). In addition, Youden's index ‘J’ is frequently used in con-
junction with the ROC curve analysis, with:
Its value ranges from 0 through 1 (inclusive). A zero value is ob-
served when a diagnostic test gives the same proportion of positive 
results for groups with and without the disease. A value of 1 indi-
cates that there are no false positives or false negatives, i.e. the test 
is perfect. In a ROC curve, the calculation of Youden's index in all 
points allows to determine the best cut-off of the test (i.e. optimal 
Youden's index).
2.3.2 | Estimation of the relative sensitivity, 
specificity of the hemagglutination inhibition 
assays and the true prevalence
The sensitivity and the specificity of the HI assays were estimated 
based on the cut-off established using the ROC curve and relatively 
on the results of the VNT as reference test. The 95% confidence 
interval of each parameter was estimated based on exact binomial 
distribution, using STATA/SE 14.2 (StataCorp.).
The animal true prevalence (TP) of IDV was estimated from the 
apparent prevalence (AP) calculated in this study using HI assays (i.e. 
the seroprevalence) and the individual diagnostic specificity (Sp) and 
sensitivity (Se) based on the ROC curve, using the Rogan and Gladen 
formula (1978):
For the AP, Sp and Se values of different HI assays, a uniform 
variable was used, taking into account the extreme values of the 95% 
confidence interval, and a stochastic modelling (1,000 Monte Carlo 
simulations) was performed using @Risk 7.5.2 software (Palisade 
Corporation, Ithaca, New York, USA) to estimate the TP with a 95% CI 
using Equation (2).
2.3.3 | Agreement between hemagglutination 
inhibition assays and virus micro-neutralization test
The correlation between the titres of HI assays and the VNT was 
assessed using the Spearman rank correlation, a non-parametric test 
(Petrie & Watson, 2013).
The two tests (positive and negative results using the cut-off se-
lected) were compared using concordance analysis to assess their 
(1)Youden�s index= sensitivity+specificity−1
(2)TP=(AP+Sp−1) ∕ (Se+Sp−1)
TA B L E  1   Origina of Moroccan bovines sampled during years 
2012–2015











Oriental High Atlas 4
Total 200
aGeographic (bioclimatic) areas with specific husbandry practices 
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agreement with the results. The level of agreement was expressed 
in terms of Cohen kappa coefficient (κ) (Petrie & Watson, 2013) and 
of indices of positive (Ppos) and negative agreement (Pne) (Cicchetti 
& Feinstein, 1990), the observed agreement proportion for positive 
and negative test results, respectively. Confidence intervals were 
calculated using an exact binomial distribution.
The Ppos and Pne were used to resolving the paradoxes of Cohen 
kappa coefficient (conditions when there is a high agreement but 
low kappa) (Cicchetti & Feinstein, 1990).
Using a ‘two-by-two’ contingency table (Table 3), the two indi-
ces of positive agreement (Ppos) and negative agreement (Pneg) were, 
respectively,
and
where Ppos and Pneg were the indices of positive and negative agree-
ment, respectively (parameters a, b, c and d are detailed in Table 3).
In addition, the comparison of titres obtained in HI assays and 
VNT was assessed with a non-parametric two-sample Wilcoxon 
rank-sum test and using a Bonferroni correction for multiple 
comparisons (alpha was fixed as 0.017, i.e. 0.05 divided by 3 
comparisons).
3  | RESULTS
3.1 | Titres of hemagglutination inhibition assays 
and virus micro-neutralization test
The titres obtained for the three tests (HI1, HI2 and VNT as refer-
ence) are depicted in Table 2 and Appendix S1. High titre of anti-
bodies was observed for all the three tests. While titres of HI1 and 
HI2 are similar (two-sample Wilcoxon rank-sum test; p-value = .51), 
titres of VNT are significantly higher than titres of HI1 and HI2 (two-
sample Wilcoxon rank-sum test; p-value ≤ .0001). Besides, according 
to Table 2, VNT was more sensitive than HI at higher titres, but less 
sensitive than HI at lower titres.
3.2 | Receiver operating characteristic (ROC) curve
The best cut-off for HI1 or HI2 was estimated based on the VNT as 
reference test and using a ROC curve (Figure 1). For the two ROC 
curves, the best positivity cut-off was the same, with a titre = 10. At 
this point estimate, the optimal Youden's indexes were observed and 
reached 0.67 and 0.64 for HI1 and HI2, respectively.
The area under the ROC curve (AUC) for HI1 and HA2 was, 
respectively, 0.84 (standard error = 0.026) and 0.83 (standard 
error = 0.025). The difference between these areas was not signifi-
cant (χ2 = 0.34; p-value = .56).
3.3 | Estimation of the sensibility and specificity of 
hemagglutination inhibition assays relative to the 
micro-neutralization as reference test
Based on the cut-off determined by the ROC curve for HI1 and HI2, 
the contingency tables were established for HI1 and HI2, respec-
tively (Tables 3 and 4).
The sensitivity and the specificity of the HI1 related to the VNT 
were 73.20% (95% CI: 63.24–81.68) and 94.17 (95% CI: 87.75–97.83), 
respectively. Youden's index for HI1 was 0.67.
The sensitivity and the specificity of the HI2 related to the VNT 
were 68.04% (95% CI: 57.80–77.15) and 96.12 (95% CI: 90.35–98.93), 
respectively. Youden's index for HI1 was 0.64.
3.4 | Estimation of the apparent and true prevalence
The apparent prevalence of IDV was estimated with HI1 and 
HI2, as, respectively, 38.50% (95% CI: 31.72–45.62) and 35.00% 
(95% CI: 28.41–42.05). There was no statistical difference in the 
(3)Ppos=2a∕ (2a+b+c)
(4)Pneg=2d∕ (2d+b+c)
TA B L E  2   Number of sera obtained in function of the assays and 
the titres obtained
Titre VNT HI1 HI2
<10 103 123 130
10 8 30 29
20 13 15 15
30 1
40 21 22 9
60 1
80 16 6 8
160 14 2 6
320 15 1 2
640 4 1 1
1,280 4
Note: HI1, hemagglutination inhibition assay using D/bovine/
Nebraska/9-5/2012; VNT; HI2, hemagglutination inhibition assay using 
D/bovine/France/5920/2014; VNT virus micro-neutralization test using 
D/bovine/France/5920/2014.
TA B L E  3   Comparison of HI1 and VNT results for influenza D in 




Positive 71(a) 26(b) 97
Negative 6(c) 97(d) 103
Total 77 123 200
Note: (a), (b), (c) and (d) are parameters used in Equations (3) and 
Equation (4).
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estimation of the apparent prevalence using HI assays (χ2(1df; 
0.05) = 0.53; p-value = .47).
Based on the sensitivity and the specificity of HI1 and HI2 and 
their above estimated apparent prevalence, the true prevalence 
was estimated using the Rogan and Gladen formula (1978): 48.73% 
(95% CI: 34.06–64.40) with HI1 and 48.44% (95% CI: 33.69–65.14) 
with HI2 (Figure 2). These two estimations were concordant (χ
2
(1df; 
0.05) = 0.1 (p-value = .92).
3.5 | Level of agreement between tests
The Spearman rank correlation between the logarithm of the titre of 
HI1 and the logarithm of the titre of VNT was 0.76 (p-value < .0001). 
The Spearman rank correlation between the logarithm of the titre of 
HI2 and the logarithm of the titre of VNT was 0.81 (p-value < .0001) 
(Figure 3). These correlations indicated a good relation between the 
titres of different tests used.
According to the cut-off of HI1 and HI2 determined previously 
(i.e. titre = 10), the level of agreement with the results of the VNT 
was calculated. The two-by-two contingency tables for two differ-
ent HI assays are depicted in Tables 3 and 4.
These HI assays were in good agreement with VNT (using the 
scale proposed by Petrie & Watson, 2013) as the Cohen kappa co-
efficient (κ) was of 0.68 (95% CI: 0.54–0.81) (p-value < .05) and 0.65 
(95% CI: 0.51–0.78) (p-value < .05) for HI1 and HI2, respectively.
The positive agreement index (Cicchetti & Feinstein, 1990) be-
tween HI assays and VNT was 0.82 (95% CI: 0.75–0.78) and 0.79 
(95% CI: 0.72–0.85) for HI1 and HI2, respectively.
The negative agreement index (Cicchetti & Feinstein, 1990) be-
tween HI assays and VNT was 0.86 (95% CI: 0.81–0.90) and 0.85 
(95% CI: 0.80–0.89) for HI1 and HI2, respectively.
The positive and negative agreement indices were not signifi-
cantly different.
4  | DISCUSSION
The interest of IDV resides in the fact that the virus was discovered 
recently (Hause et al., 2014; Hause et al., 2013), harbours a RNA 
genome with a high rate of mutations (Kesinger et al., 2018), circu-
lates worldwide in livestock, may play a role in the bovine respira-
tory complex (Salem et al., 2019; Zhang, Hill, et al., 2019; Zhang, 
Outlaw, et al., 2019) and has a zoonotic potential (e.g. Borkenhagen 
et al., 2018; Hause et al., 2013; Holwerda et al., 2019).
In this study, the positivity cut-off of the HI assays was for-
mally established (titre = 10) for cattle in field conditions using a 
ROC curve. This information was used to estimate the sensitiv-
ity (between 68.04% and 73.20%) and the specificity (between 
94.17% and 96.12%) of HI assays relatively to the VNT as refer-
ence test. Based on the above characteristics, the true prevalence 
of the IDV was then estimated in Morocco using a stochastic ap-
proach. Irrespective of the antigen used in HI assays, the estima-
tion of the true prevalence was statistically equivalent (between 
48.44% and 48.73%). In addition, the Spearman rank correlation 
between HI and VNT titres was statistically good (0.76 and 0.81 
for HA1 and HA2, respectively). The positive (0.82 and 0.79 for 
HA1 and HA2, respectively) and the negative (0.86 and 0.85 for 
HA1 and HA2, respectively) agreement indices between HI assays 
and VNT were good and similar. In addition, the VNT was also less 
sensitive than HI at lower titres. In humans, for influenza A, a good 
correlation between HI and VNT titres and the lesser sensitivity 
than HI at lower titres were also previously observed (Truelove 
et al., 2016). Like for influenza A, the reason is unknown and 
needs more investigation (Truelove et al., 2016). Indeed, as for in-
fluenza A (Truelove et al., 2016), the use of HI assay for detection 
of antibodies against IDV is supported over the more resource 
intensive VNT (i.e. requires cell culture, more time and labour, and 
technical skill to conduct the assay compared to other serological 
methods) (Gauger & Vincent, 2020).
Despite the genetic distance between the hemagglutinin-es-
terase fusion (HEF) genes of the two strains of IDV (Chiapponi 
et al., 2019), no statistical difference was observed in the 
F I G U R E  1   Receiver operating characteristic (ROC) curve 
based on hemagglutination inhibition assays and virus micro-
neutralization test as reference. HI1, hemagglutination 
inhibition assay using D/bovine/Nebraska/9-5/2012; VNT; 
HI2, hemagglutination inhibition assay using D/bovine/
France/5920/2014; the reference test was the virus micro-
neutralization test using D/bovine/France/5920/2014. The asterisk 
indicates the best cut-off of the two HI assays (titre = 10)
TA B L E  4   Comparison of HI2 and VNT results for influenza D in 




Positive 66 31 97
Negative 4 99 103
Total 70 130 200
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characteristics of the two HI assays. Indeed, the same formal cut-off 
can be proposed for both tests. The antigenic differences between 
the two viruses therefore do not alter the degree of detection of 
anti-IDV antibodies in this cohort of Moroccan cattle sera. However, 
similar studies regarding other species are needed.
Until currently, the establishment of cut-off of HI assays was not 
formalized for the detection of antibodies directed to IDV. Previous 
studies have used titres of 10–40 as thresholds for IDV positive anti-
body titres (Luo et al., 2017; Salem et al., 2017). This establishment is 
of prime importance to assess the diagnostic sensitivity and specificity 
of HI assays, to compare seroprevalence studies (and thus geographi-
cal areas) and to calculate the true prevalence of IDV. In addition, the 
recent development of monoclonal-based competitive ELISA used HI 
as reference test (Moreno et al., 2019) and emphasizes the importance 
of the establishment of a formal cut-off for any HI assay.
Among the mitigation measure against IDV, the vaccination is 
a credible option (e.g. Wan et al., 2018), especially in its main host, 
i.e. cattle (Dane et al., 2019; Salem et al., 2019). The choice of any 
strategy is based on the estimation of the cost–benefit ratio (e.g. 
Renault et al., 2019; Souley Kouato et al., 2018). Indeed, to be able 
F I G U R E  2   Stochastic estimation 
of the true prevalence based on 
hemagglutination inhibition assays 
([a] = HI1; [b] = HI2) (1,000 iterations)
F I G U R E  3   Correlation between 
hemagglutination inhibition assays 
([a] = HI1; [b] = HI2) and the virus 
micro-neutralization for the detection 
of antibodies directed against influenza 
D virus
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to quantify the cost (in monetary terms), one needs the estimation 
of the true prevalence of IDV. For the development of future ELISA 
tests (i.e. screening tools for the detection of antibodies against IDV), 
a validation with at least an HI assay (e.g. Moreno et al., 2019) fol-
lowed by inference of VNT using the methodology developed in this 
study or by the direct use of VNT as reference test is recommended.
One limitation of this study is the absence of complete sam-
pling design, which needs a good knowledge of the sampling frame. 
However, sera of this study were sampled in numerous regions of 
Morocco to give a good representability of the cattle population.
The present study and methodology should be extended to sam-
ples from other continents (and/or other circulating strains of IDV) 
and other species in the purpose to consolidate the formal positivity 
cut-off of HI assays proposed here.
5  | CONCLUSION
This study allowed to formally establishing the positivity cut-off of 
the HI assays for the detection of antibodies directed against IDV. 
This information is of prime importance to estimate the diagnostic 
sensitivity and specificity of the test relatively to the VNT, which is 
the reference test. Using these characteristics, the true prevalence 
of IDV should be determined in a country.
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